STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Stereotaxis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $101.03M
- P/E (TTM)
- –
- Dividend yield
- –
Stereotaxis, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disposables Service and Accessories [Member] | $6.19M | $4.97M | $5.28M | $5.60M | $5.76M | $5.51M | $4.95M | $4.81M | $4.26M | $4.27M | $4.50M | $4.26M | 80.7% | +7.5% |
| Systems [Member] | $1.48M | $1.32M | $3.36M | $1.86M | $3.04M | $1.96M | $1.39M | $4.39M | $240.00K | $2.61M | $66.00K | $3.54M | 19.3% | -51.3% |
| Royalty [Member] | $0 | $0 | – | $0 | $0 | $0 | – | $0 | $0 | $100.00K | – | – | 0.0% | – |
By region
From the segment and revenue-disaggregation notes of Stereotaxis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.